Who backs Cardurion?
16 investors| Investor | Type |
|---|---|
| Fidelity Management & Research Company | Asset manager |
| GV | Venture capital |
| New Enterprise Associates | Venture capital |
| Blue Owl Capital | — |
| Bain Capital | PE / buyout |
| Polaris Partners | Venture capital |
| The Invus Group | PE / buyout |
| Digitalis Ventures | Venture capital |
| Bain Capital Life Sciences | Venture capital |
| Farallon Capital Management | Hedge fund |
| + 6 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Cardurion investors
16 investors are on record for Cardurion, including Fidelity Management & Research Company, GV, New Enterprise Associates and Blue Owl Capital. By type, the record holds 6 venture capital firms, 2 hedge funds and 2 private equity firms. The Series B in Jul 2024 drew 11 investors.
Free account
More of Cardurion with a free account
- ·The complete investor list: 16 names
- ·Watch Cardurion: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 16 firms already write checks for companies like Cardurion in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View